GO:0051385 response to mineralocorticoid: Aldosterone Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051385 response to mineralocorticoid describes any cellular or organismal change triggered by mineralocorticoid hormones such as aldosterone, which regulate water and electrolyte balance.
• Mineralocorticoids are C21 corticosteroids synthesized from cholesterol; their actions are mediated primarily by the mineralocorticoid receptor (NR3C2), which controls gene expression in transport epithelia.
• Key effector genes include SGK1, which determines kidney function and salt intake under mineralocorticoid excess, and AQP3, which is regulated by mineralocorticoids in collecting duct cells.
• Mineralocorticoid receptor blockade influences the cortisol response to psychological stress, linking this process to neuroendocrine stress regulation.
• Dysregulation of mineralocorticoid signaling is implicated in adrenal cortical carcinoma, cardiovascular and renal disorders, and inflammatory conditions such as sepsis.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of mineralocorticoid-responsive genes in vitro and in vivo.
Description
GO:0051385 response to mineralocorticoid is a Gene Ontology biological process term that captures any change in a cell or organism resulting from a mineralocorticoid stimulus. Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone; they act primarily on water and electrolyte balance. This term is essential for researchers studying adrenal physiology, renal ion transport, and cardiovascular homeostasis because it provides a standardized framework to annotate genes and pathways that respond to aldosterone and related steroids. The process is experimentally defined by measurable outputs such as changes in gene expression, enzyme production, secretion, or movement of ions and water. Classic studies have shown that low-dose adrenocorticotropin infusion can elicit mineralocorticoid responses, demonstrating the sensitivity of this axis to physiological stimuli. In the kidney, mineralocorticoid signaling regulates the expression of transport proteins and channels, including aquaporins and kinases, to maintain sodium and potassium balance. Beyond renal physiology, mineralocorticoid responses intersect with neuroendocrine stress regulation and immune function. Pharmacological blockade of mineralocorticoid and glucocorticoid receptors alters the cortisol response to psychological stress, indicating that this process is embedded in broader stress-response networks. In sepsis, corticosteroids exert immune effects that may involve mineralocorticoid receptor-dependent mechanisms, highlighting the clinical relevance of this GO term. Understanding GO:0051385 therefore supports research across endocrinology, nephrology, immunology, and oncology.
response to mineralocorticoid At A Glance
| GO ID | GO:0051385 |
|---|---|
| GO term | response to mineralocorticoid |
| Ontology | biological_process |
| Synonym | response to mineralocorticoid stimulus |
| Major function | Mediates cellular and organismal changes in response to mineralocorticoid hormones, primarily regulating water and electrolyte balance |
| Definition source | QuickGO |
| Example hormones | Aldosterone, deoxycorticosterone, and related C21 corticosteroids |
| Primary receptor | Mineralocorticoid receptor (NR3C2) |
| Key effector genes | SGK1, AQP3, and other transport and signaling genes |
| Related diseases | Adrenal cortical carcinoma, cardiovascular and renal disorders, sepsis-associated inflammation |
What Is GO:0051385?
In simple terms, GO:0051385 response to mineralocorticoid is the collection of cellular and physiological changes that occur when a cell or organism encounters a mineralocorticoid hormone such as aldosterone. According to the QuickGO definition, it is any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mineralocorticoid stimulus. Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone, and they act primarily on water and electrolyte balance. The term has the synonym response to mineralocorticoid stimulus and is classified as a biological process.
Why Is response to mineralocorticoid Important in Cell Biology?
GO:0051385 response to mineralocorticoid is critically important because mineralocorticoid signaling is a central regulator of blood pressure, sodium and potassium homeostasis, and extracellular fluid volume. Dysregulation of this process contributes to hypertension, heart failure, renal dysfunction, and adrenal disorders, making it a key target for both mechanistic research and therapeutic development. Moreover, mineralocorticoid responses intersect with stress and immune pathways, as shown by studies on receptor blockade and cortisol responses and by research on corticosteroids in sepsis. Understanding this term at the molecular level enables researchers to identify causal genes, design targeted experiments, and interpret omics data in the context of endocrine physiology.
• Regulates water and electrolyte balance, which is fundamental for blood pressure and fluid homeostasis.
• Controls expression of renal transport proteins such as AQP3 in collecting duct cells.
• SGK1 acts as a determinant of kidney function and salt intake under mineralocorticoid excess.
• Mineralocorticoid receptor blockade modulates the cortisol response to psychological stress, linking the process to neuroendocrine regulation.
• Low-dose adrenocorticotropin infusion can elicit mineralocorticoid responses, showing the sensitivity of the adrenal axis.
• Adrenal cortical carcinoma can disrupt mineralocorticoid production and signaling.
• Corticosteroid immune effects in sepsis may involve mineralocorticoid receptor-dependent mechanisms.
• Provides a standardized annotation for genes and pathways in endocrine, renal, and cardiovascular research.
• Supports the development of CRISPR models to test causality of mineralocorticoid-responsive genes.
• Helps interpret transcriptomic and proteomic data in studies of aldosterone action and receptor pharmacology.
What Happens During response to mineralocorticoid?
Hormone synthesis and availability
In simple terms: The body makes mineralocorticoid hormones from cholesterol, and their levels can change with physiological demand.
Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone. Their production occurs primarily in the adrenal cortex, and circulating levels can be influenced by adrenocorticotropic signals; for example, low-dose adrenocorticotropin infusion can elicit mineralocorticoid responses in vivo. This step determines the amount of ligand available to initiate the response.
Receptor binding and transcriptional regulation
In simple terms: The hormone binds to a receptor inside cells, which then turns genes on or off.
The mineralocorticoid receptor (NR3C2) binds aldosterone and related mineralocorticoids, leading to changes in gene expression. This receptor-mediated transcriptional regulation is a core mechanism by which mineralocorticoids alter cell state and activity, including enzyme production and secretion. Pharmacological blockade of mineralocorticoid receptors can modify downstream responses such as the cortisol response to psychological stress, demonstrating the receptor's functional importance.
Regulation of ion and water transport in the kidney
In simple terms: In the kidney, the response adjusts channels and transporters to control salt and water.
Mineralocorticoid signaling regulates the expression of transport proteins in the collecting duct; for example, AQP3 expression is regulated in response to mineralocorticoid. SGK1 acts as a determinant of kidney function and salt intake under conditions of mineralocorticoid excess. These molecular changes translate into altered sodium reabsorption, potassium secretion, and water balance, which are hallmarks of the response to mineralocorticoid.
Integration with stress and immune pathways
In simple terms: The response does not act alone; it connects with stress hormones and immune signals.
Mineralocorticoid receptor blockade influences the cortisol response to psychological stress, indicating cross-talk between mineralocorticoid and glucocorticoid systems. In sepsis, corticosteroids exert immune effects that may involve mineralocorticoid receptor-dependent mechanisms, linking this process to inflammatory regulation. Thus, the response to mineralocorticoid is integrated into broader neuroendocrine and immune networks.
Physiological and pathophysiological outcomes
In simple terms: The final result can be normal fluid balance or, when dysregulated, disease.
The coordinated changes in gene expression, ion transport, and water movement maintain electrolyte balance under normal conditions. However, excessive or inappropriate mineralocorticoid signaling contributes to disorders such as adrenal cortical carcinoma and cardiovascular/renal pathology. Understanding these outcomes is essential for targeting the pathway in disease.
Key Genes Involved in GO:0051385 response to mineralocorticoid
The following genes and proteins are central to the response to mineralocorticoid, based on published literature and their roles in receptor signaling, ion transport, and related physiological processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NR3C2 | Mineralocorticoid receptor; binds aldosterone and mediates transcriptional responses | Primary receptor for studying mineralocorticoid action and receptor blockade |
| SGK1 | Serum/glucocorticoid-regulated kinase 1; determinant of kidney function and salt intake under mineralocorticoid excess | Key effector for salt handling and renal physiology |
| AQP3 | Aquaporin 3; water channel regulated in collecting duct in response to mineralocorticoid | Marker of mineralocorticoid-responsive water transport |
| SCNN1A | Epithelial sodium channel alpha subunit; mediates sodium reabsorption | Downstream target of aldosterone signaling in kidney |
| SCNN1B | Epithelial sodium channel beta subunit; contributes to sodium transport | Component of the mineralocorticoid-sensitive sodium channel complex |
| SCNN1G | Epithelial sodium channel gamma subunit; regulates channel activity | Potential target for studying mineralocorticoid-dependent sodium transport |
| ATP1A1 | Na+/K+-ATPase alpha 1 subunit; maintains electrochemical gradient | Effector of electrolyte balance in mineralocorticoid-responsive tissues |
| ATP1B1 | Na+/K+-ATPase beta 1 subunit; supports pump function | Related to ion transport in kidney and other epithelia |
| HSD11B2 | 11-beta-hydroxysteroid dehydrogenase type 2; inactivates cortisol to protect mineralocorticoid receptor | Determines ligand specificity for mineralocorticoid receptor |
| POMC | Proopiomelanocortin; precursor for ACTH and other peptides | Links adrenal stimulation to mineralocorticoid responses |
| CYP11B2 | Aldosterone synthase; catalyzes final steps of aldosterone synthesis | Enzyme for mineralocorticoid biosynthesis from cholesterol |
| CYP11B1 | 11-beta-hydroxylase; involved in cortisol and corticosteroid synthesis | Related to adrenal steroidogenesis |
| NR3C1 | Glucocorticoid receptor; cross-talks with mineralocorticoid signaling | Relevant to stress response and receptor blockade studies |
| FKBP5 | FK506-binding protein 5; modulates steroid receptor sensitivity | Potential modulator of mineralocorticoid/glucocorticoid cross-talk |
| IL6 | Interleukin 6; inflammatory cytokine influenced by corticosteroids | Immune effects of corticosteroids in sepsis |
| TNF | Tumor necrosis factor; inflammatory mediator | Corticosteroid immune modulation in sepsis |
| NFKB1 | Nuclear factor kappa B subunit 1; transcription factor in inflammation | Cross-talk between mineralocorticoid signaling and immune pathways |
| SGK3 | Serum/glucocorticoid-regulated kinase family member | Potential compensatory kinase in mineralocorticoid-responsive tissues |
How Is response to mineralocorticoid Regulated?
The response to mineralocorticoid is regulated at multiple levels. Ligand availability depends on adrenal steroidogenesis from cholesterol and can be influenced by adrenocorticotropic signals, as low-dose adrenocorticotropin infusion elicits mineralocorticoid responses. At the receptor level, the mineralocorticoid receptor (NR3C2) activity can be modulated by pharmacological blockade, which alters downstream cortisol responses to stress. In target tissues, the enzyme HSD11B2 controls ligand access by inactivating cortisol, thereby ensuring specificity of mineralocorticoid action. Downstream effectors such as SGK1 and AQP3 are transcriptionally regulated and determine the magnitude of ion and water transport changes. Additionally, cross-talk with glucocorticoid receptors and immune signaling pathways provides further regulatory layers, as seen in stress and sepsis models.
response to mineralocorticoid and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR3C2 | Hypertension and electrolyte disorders | Knockout or point-mutation cell models to test receptor function |
| SGK1 | Salt-sensitive hypertension and renal dysfunction | Kidney-specific knockout or overexpression models |
| AQP3 | Water balance disorders and collecting duct dysfunction | Collecting duct cell lines with AQP3 knockout or knock-in |
| CYP11B2 | Adrenal cortical carcinoma and aldosterone excess | Adrenal cell models with CYP11B2 knockout or overexpression |
| HSD11B2 | Mineralocorticoid excess syndromes | Knockout or point-mutation models to assess ligand specificity |
Adrenal cortical carcinoma and mineralocorticoid excess
Adrenal cortical carcinoma is a rare but aggressive malignancy that can disrupt normal adrenal steroidogenesis, including mineralocorticoid production. Excessive or dysregulated mineralocorticoid signaling may contribute to hypertension and electrolyte abnormalities in affected patients. Research on this disease often focuses on identifying molecular drivers and testing targeted therapies that modulate steroidogenic pathways.
Cardiovascular and renal disorders
Mineralocorticoid signaling is a key regulator of blood pressure and fluid balance, and its dysregulation is implicated in hypertension, heart failure, and renal dysfunction. SGK1 and AQP3 are downstream effectors that mediate salt and water handling, and their altered expression can contribute to pathology. Mineralocorticoid receptor antagonists are used clinically to mitigate these effects, underscoring the therapeutic relevance of this pathway.
Stress-related and neuroendocrine conditions
Pharmacological blockade of mineralocorticoid and glucocorticoid receptors influences the cortisol response to psychological stress, suggesting that mineralocorticoid signaling participates in stress regulation. Dysregulation of this axis may be relevant to stress-related psychiatric and metabolic conditions, although further research is needed to establish causal mechanisms.
Sepsis and inflammatory diseases
Corticosteroids have immune effects in sepsis, and some of these effects may be mediated through mineralocorticoid receptor-dependent pathways. Inflammatory cytokines such as IL6 and TNF are modulated by corticosteroid treatment, and understanding the contribution of mineralocorticoid signaling could inform therapeutic strategies.
From response to mineralocorticoid-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NR3C2 mediate transcriptional responses to aldosterone? | NR3C2 knockout cell line (e.g., renal epithelial cells) |
| What is the role of SGK1 in salt handling under mineralocorticoid excess? | SGK1 knockout or overexpression in kidney cell models |
| How does AQP3 respond to mineralocorticoid stimulation? | AQP3 promoter-reporter knock-in or tagged knock-in in collecting duct cells |
| Does a point mutation in NR3C2 alter ligand binding or transactivation? | Point-mutation knock-in cell lines expressing mutant receptor |
| Can overexpression of CYP11B2 drive mineralocorticoid excess phenotypes? | CYP11B2 overexpression in adrenal or heterologous cell models |
| What is the impact of mineralocorticoid receptor blockade on stress-related gene expression? | CRISPR knockout of NR3C2 combined with pharmacological blockade in neuronal cell models |
How to Study the response to mineralocorticoid Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global changes in gene expression | Identify mineralocorticoid-responsive genes |
| Phosphoproteomics | Changes in protein phosphorylation | Discover SGK1 substrates and signaling networks |
| Electrophysiology | Ion channel activity and transport | Assess sodium/potassium flux in epithelial cells |
| Water permeability assay | Aquaporin-mediated water transport | Measure AQP3 function in collecting duct cells |
| CRISPR knockout screen | Gene essentiality or modifier effects | Identify novel regulators of mineralocorticoid response |
| Reporter gene assay | Transcriptional activity of mineralocorticoid receptor | Test receptor mutants or pharmacological modulators |
| ELISA | Hormone or cytokine levels | Quantify aldosterone, cortisol, or inflammatory markers |
| Western blot | Protein expression and modification | Validate changes in SGK1, AQP3, or NR3C2 |
Transcriptomic profiling of mineralocorticoid responses
RNA sequencing (RNA-seq) can identify global changes in gene expression following mineralocorticoid stimulation or receptor blockade. This approach is useful for discovering novel effector genes and validating known targets such as SGK1 and AQP3. Differential expression analysis helps pinpoint pathways that are causally linked to the response.
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation downstream of mineralocorticoid receptor activation. Since SGK1 is a kinase, phosphoproteomics is particularly suited to identify its substrates and signaling networks. These methods complement transcriptomic data by capturing post-transcriptional regulation.
Functional assays for ion and water transport
Electrophysiological and flux assays measure sodium and potassium transport in epithelial cells, providing functional readouts of mineralocorticoid action. Water permeability assays can assess AQP3 function in collecting duct cells. These methods link molecular changes to physiological outcomes.
CRISPR-based genetic screens
Pooled CRISPR knockout or activation screens can systematically identify genes that modify the response to mineralocorticoid. Such screens are powerful for uncovering novel regulators and validating candidate genes in a high-throughput manner. Hits can then be tested in focused functional assays.
How CRISPR Can Be Used to Study GO:0051385 response to mineralocorticoid
Knockout
CRISPR knockout of NR3C2, SGK1, or AQP3 can abolish or reduce specific arms of the response to mineralocorticoid, enabling causal inference. For example, SGK1 knockout models have been used to demonstrate its role in kidney function and salt intake under mineralocorticoid excess. Knockout cell lines are also valuable for validating antibody specificity and for transcriptomic baseline comparisons.
Point Mutation
Point mutations in NR3C2 can be introduced to dissect ligand-binding or transactivation domains, revealing structure-function relationships. Such models are useful for studying receptor variants that may alter sensitivity to mineralocorticoids or pharmacological antagonists. Point-mutation knock-in cell lines provide a controlled system to test hypotheses about specific residues.
Knock-in
Knock-in of reporter tags or fluorescent proteins into endogenous loci such as AQP3 or SGK1 allows real-time monitoring of expression and localization in response to mineralocorticoid stimulation. Tagged knock-in models preserve native regulatory elements, offering physiological relevance. These tools are ideal for imaging and biochemical studies.
Overexpression
Overexpression of CYP11B2 or SGK1 can mimic mineralocorticoid excess states and drive downstream phenotypes in cell or animal models. Such models help identify the consequences of pathway hyperactivation and can be used to test therapeutic interventions. Overexpression systems are also useful for producing sufficient protein for biochemical assays.
How EDITGENE Supports response to mineralocorticoid Research
Researchers studying response to mineralocorticoid-related genes often need to determine whether a candidate gene is causally involved in hormone sensing, ion transport, or downstream physiological outcomes. Generating precise genetic models is essential to move from correlation to causation, and CRISPR-based approaches provide the flexibility to knockout, mutate, tag, or overexpress target genes in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for response to mineralocorticoid research.
Frequently Asked Questions About response to mineralocorticoid
What is GO:0051385 response to mineralocorticoid?
GO:0051385 is a Gene Ontology biological process term describing any change in a cell or organism resulting from a mineralocorticoid stimulus, such as aldosterone, primarily affecting water and electrolyte balance.
What genes are involved in response to mineralocorticoid?
Key genes include NR3C2 (mineralocorticoid receptor), SGK1, AQP3, SCNN1A/B/G, ATP1A1/B1, HSD11B2, CYP11B2, and others involved in ion transport and steroidogenesis.
How does aldosterone regulate gene expression?
Aldosterone binds the mineralocorticoid receptor (NR3C2), which translocates to the nucleus and modulates transcription of target genes such as SGK1 and AQP3.
What is the role of SGK1 in mineralocorticoid signaling?
SGK1 is a kinase that acts as a determinant of kidney function and salt intake under mineralocorticoid excess, influencing sodium transport and blood pressure.
How is AQP3 regulated by mineralocorticoids?
AQP3 expression in collecting duct cells is regulated in response to mineralocorticoid, contributing to water reabsorption and balance.
Can mineralocorticoid receptor blockade affect stress responses?
Yes, pharmacological blockade of mineralocorticoid and glucocorticoid receptors influences the cortisol response to psychological stress.
What diseases are associated with mineralocorticoid dysregulation?
Dysregulation is linked to adrenal cortical carcinoma, hypertension, heart failure, renal disorders, and inflammatory conditions such as sepsis.
How can CRISPR be used to study response to mineralocorticoid?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes like NR3C2, SGK1, and AQP3 in mineralocorticoid-responsive pathways.
What experimental models are suitable for mineralocorticoid research?
Renal epithelial cell lines, adrenal cell models, and knockout or transgenic animals are commonly used to study mineralocorticoid responses.
Where can I get custom CRISPR cell models for mineralocorticoid genes?
EDITGENE provides custom knockout, point-mutation, knock-in, overexpression, and library screening services for mineralocorticoid-related genes.
Conclusion
GO:0051385 response to mineralocorticoid is a fundamental biological process that governs water and electrolyte balance through aldosterone and related hormones. Its molecular dissection has revealed key effectors such as SGK1 and AQP3, and its dysregulation is implicated in cardiovascular, renal, and inflammatory diseases. Continued research using precise genetic models will further clarify causal mechanisms and therapeutic opportunities. By leveraging CRISPR-based knockout, point-mutation, knock-in, and overexpression strategies, researchers can interrogate the response to mineralocorticoid with unprecedented resolution. EDITGENE offers comprehensive services to support these efforts, from custom cell model generation to high-throughput screening and bioinformatics analysis.
References
- 1. Kemppainen RJ et al.. 1997. Adrenal physiology.. Vet Clin North Am Small Anim Pract 27(2):173-86 PMID: 9076902
- 2. Deuter CE et al.. 2024. The influence of pharmacological mineralocorticoid and glucocorticoid receptor blockade on the cortisol response to psychological stress.. Prog Neuropsychopharmacol Biol Psychiatry 129:110905 PMID: 38043634
- 3. Tuck ML et al.. 1981. Mineralocorticoid response to low dose adrenocorticotropin infusion.. J Clin Endocrinol Metab 52(3):440-6 PMID: 6257748
- 5. Boushey RP et al.. 2001. Adrenal cortical carcinoma.. Curr Treat Options Oncol 2(4):355-64 PMID: 12057116
- 6. Kwon TH et al.. 2002. Regulation of collecting duct AQP3 expression: response to mineralocorticoid.. Am J Physiol Renal Physiol 283(6):F1403-21 PMID: 12388415
- 7. Vallon V et al.. 2005. SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess.. Am J Physiol Regul Integr Comp Physiol 289(2):R395-R401 PMID: 16014448
- 8. Heming N et al.. 2018. Immune Effects of Corticosteroids in Sepsis.. Front Immunol 9:1736 PMID: 30105022
